Advertisement
Journal Home
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

661 Periodical Search Results

You searched for "ovarian cancer" OR "ovarian ca" OR "cancer of ovary" OR "malignant tumor of ovary" OR "malignant tumour of ovary" within European Journal of Cancer

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 661 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

display abstract citation download email a colleague
Display:

  1. Does sunlight prevent cancer? A systematic review
    H.J. van der Rhee, E. de Vries, J.W.W. Coebergh
    European Journal of Cancer
    September 2006 (Vol. 42, Issue 14, Pages 2222-2232)
    Abstract | Full Text | Full-Text PDF (162 KB)

  1. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
    Antonio Sica, Tiziana Schioppa, Alberto Mantovani, Paola Allavena
    European Journal of Cancer
    April 2006 (Vol. 42, Issue 6, Pages 717-727)
    Abstract | Full Text | Full-Text PDF (448 KB)

  1. Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: A cost-effectiveness analysis , 25 March 2008
    Jan Norum, Anne Irene Hagen, Lovise Mæhle, Jaran Apold, John Burn, Pål Møller
    European Journal of Cancer
    May 2008 (Vol. 44, Issue 7, Pages 963-971)
    Abstract | Full Text | Full-Text PDF (205 KB)

  1. Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours , 22 July 2008
    S. Cresta, C. Sessa, C.V. Catapano, E. Gallerani, D. Passalacqua, A. Rinaldi, F. Bertoni, L. Viganò, M. Maur, G. Capri, E. Maccioni, D. Tosi, L. Gianni
    European Journal of Cancer
    September 2008 (Vol. 44, Issue 13, Pages 1829-1834)
    Abstract | Full Text | Full-Text PDF (260 KB) | Add-Ons

  1. Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer , 12 October 2009
    J. Dauplat, G. Chene, C. Pomel, M.M. Dauplat, G.Le Bouëdec, F. Mishellany, N. Lagarde, Y.J. Bignon, P. Jaffeux, B. Aublet-Cuvelier, P. Dechelotte, J.L. Pouly, F. Penault-Llorca
    European Journal of Cancer
    November 2009 (Vol. 45, Issue 17, Pages 2977-2983)
    Abstract | Full Text | Full-Text PDF (345 KB)

  1. Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer Corrected Proof, 18 November 2009
    Liangdan Tang, Junzheng Yang, Shu-Kay Ng, Noah Rodriguez, Pui-Wah Choi, Allison Vitonis, Kui Wang, Geoffrey J. McLachlan, Robert J. Caiazzo, Brian C.-S. Liu, William R. Welch, Daniel W. Cramer, Ross S. Berkowitz, Shu-Wing Ng
    European Journal of Cancer
    DOI: 10.1016/j.ejca.2009.10.003
    Abstract | Full Text | Full-Text PDF (4449 KB) | Add-Ons

  1. Poly(ADP-ribose) polymerase inhibitors in cancer treatment: A clinical perspective Corrected Proof, 19 November 2009
    Shahneen K. Sandhu, Timothy A. Yap, Johann S. de Bono
    European Journal of Cancer
    DOI: 10.1016/j.ejca.2009.10.021
    Abstract | Full Text | Full-Text PDF (258 KB)

  1. Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer Corrected Proof, 09 November 2009
    C.G. Gerestein, G.M. Nieuwenhuyzen-de Boer, M.J. Eijkemans, G.S. Kooi, C.W. Burger
    European Journal of Cancer
    DOI: 10.1016/j.ejca.2009.10.017
    Abstract | Full Text | Full-Text PDF (207 KB)

  1. Gemcitabine in ovarian cancer: An overview of safety and efficacy
    M. Kaufmann, G. von Minckwitz
    European Journal of Cancer
    January 1997 (Vol. 33Supplement 1, Pages S31-S33)
    Abstract | Abstract + References | Full-Text PDF (309 KB)

  1. A phase II study of carboplatin and hexamethylmelamine as induction chemotherapy in advanced epithelial ovarian carcinoma
    G.B. Kristensen, M. Baekelandt, I.B. Vergote, C. Trope
    European Journal of Cancer
    October 1995 (Vol. 31, Issue 11, Pages 1778-1780)
    Abstract | Abstract + References | Full-Text PDF (275 KB)

  1. Ovarian cancer: Diagnostic second laparotomy and salvage intra-peritoneal chemotherapy fail again
    S.E. Vogl
    European Journal of Cancer
    1995 (Vol. 31, Issue 5, Pages 651-653)
    Abstract + References | Full-Text PDF (436 KB)

  1. Paclitaxel in recurrent ovarian cancer: Better upfront? Comments on: A phase II study of paclitaxel in platinum pretreated ovarian cancer. A hellenic cooperative oncology group study. EurJ Cancer 1977, 33, 160–163.
    V.R. Bulusu
    European Journal of Cancer
    October 1997 (Vol. 33, Issue 11, Pages 1905-1906)
    Abstract + References | Full-Text PDF (241 KB)

  1. Phase II trial of epirubicin at standard dose in relapsed ovarian cancer
    I. Peláez, A.J. Lacave, I. Palacio, E. Alvarez, J.F. Cueva, I. Muñiz, F. Arranz, J. Fra
    European Journal of Cancer
    May 1996 (Vol. 32, Issue 5, Pages 899-900)
    Abstract + References | Full-Text PDF (272 KB)

  1. Causes of postoperative mortality after surgery for ovarian cancer , 17 July 2009
    C.G. Gerestein, R.A.M. Damhuis, M. de Vries, A. Reedijk, C.W. Burger, G.S. Kooi
    European Journal of Cancer
    November 2009 (Vol. 45, Issue 16, Pages 2799-2803)
    Abstract | Full Text | Full-Text PDF (140 KB)

  1. Cancer-related fatigue: A critical appraisal
    G. Prue, J. Rankin, J. Allen, J. Gracey, F. Cramp
    European Journal of Cancer
    May 2006 (Vol. 42, Issue 7, Pages 846-863)
    Abstract | Full Text | Full-Text PDF (237 KB)

  1. Management and survival of ovarian cancer patients in South East England
    C.D.A. Wolfe, K. Tilling, K.S. Raju
    European Journal of Cancer
    October 1997 (Vol. 33, Issue 11, Pages 1835-1840)
    Abstract | Abstract + References | Full-Text PDF (677 KB)

  1. A phase I–II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer
    G. Bolis, G. Scarfone, F. Zanaboni, A. Villa, M. Presti, M. Melpignano, C. Ferraris, S. Tateo, P. Guarnerio, A. Gentile, F. Parazzini
    European Journal of Cancer
    April 1997 (Vol. 33, Issue 4, Pages 592-595)
    Abstract | Abstract + References | Full-Text PDF (514 KB)

  1. A phase II study of paclitaxel in platinum pretreated ovarian cancer. A hellenic cooperative oncology group study
    G. Aravantinos, D.V. Skarlos, P. Kosmidis, A. Athanassiades, D. Bafaloukos, T. Giannakakis, S. Karpathios, G. Fountzilas
    European Journal of Cancer
    January 1997 (Vol. 33, Issue 1, Pages 160-163)
    Abstract | Abstract + References | Full-Text PDF (427 KB)

  1. Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with platinum
    A. du Bois, H.J. Lück, K. Buser, H.G. Meerpohl, C. Sessa, U. Klaassen, H. Meden, H. Bochtler, K. Diergarten
    European Journal of Cancer
    March 1997 (Vol. 33, Issue 3, Pages 379-384)
    Abstract | Abstract + References | Full-Text PDF (693 KB)

  1. Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: Clinical results in patients with minimal residual disease of ovarian cancer
    F. Crippa, G. Bolis, E. Seregni, N. Gavoni, G. Scarfone, C. Ferraris, G.L. Buraggi, E. Bombardieri
    European Journal of Cancer
    1995 (Vol. 31, Issue 5, Pages 686-690)
    Abstract | Abstract + References | Full-Text PDF (621 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 661 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement

Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.